Emerging evidence indicates that LCN2 is synthesized and secreted from activated glial cells and is recognized as a modulatory factor for neuronal excitability and synaptic plasticity in response to CNS disorders (56). The gene discussed is LCN2; the disease is central nervous system disorder.